Dupilumab for the treatment of asthma

Santini, G; Mores, N; Malerba, M; Mondino, C; Anzivino, R; Macis, G; Montuschi, P

Montuschi, P (reprint author), Univ Cattolica Sacro Cuore, Univ Hosp Agostino Gemelli Fdn, Dept Pharmacol, Fac Med, Rome, Italy.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017; 26 (3): 357

Abstract

Introduction: Dupilumab (REGN668/SAR231893), produced by a collaboration between Regeneron and Sanofi, is a monoclonal antibody currently in phase III......

Full Text Link